Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* immunocompromised or under immunosuppressive treatment * subject with a history of covid hospitalized in intensive care * subject allergic to one of the components of the vaccines used in the study * subject vaccinated for covid-19 * subject with persistent symptoms of covid-19 (long covid) * subjects with unstable chronic pathology * persons deprived of liberty, hospitalized without consent * pregnant or breastfeeding woman	* immunocompromised or under immunosuppressive treatment * subject with a history of covid hospitalized in intensive care * subject allergic to one of the components of the vaccines used in the study * subject vaccinated for covid-19 * subject with persistent symptoms of covid-19 (long covid) * subjects with unstable chronic pathology * persons deprived of liberty, hospitalized without consent * pregnant or breastfeeding woman
Sept. 21, 2021, 5:30 a.m.	usa	- immunocompromised or under immunosuppressive treatment - subject with a history of covid hospitalized in intensive care - subject allergic to one of the components of the vaccines used in the study - subject vaccinated for covid-19 - subject with persistent symptoms of covid-19 (long covid) - subjects with unstable chronic pathology - persons deprived of liberty, hospitalized without consent - pregnant or breastfeeding woman	- immunocompromised or under immunosuppressive treatment - subject with a history of covid hospitalized in intensive care - subject allergic to one of the components of the vaccines used in the study - subject vaccinated for covid-19 - subject with persistent symptoms of covid-19 (long covid) - subjects with unstable chronic pathology - persons deprived of liberty, hospitalized without consent - pregnant or breastfeeding woman